derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico
"derivados do ciclohexanol espirocíclicos". a invenção está relacionada com os derivados do ciclohexanol espirocíclicos, um método para a produção dos mesmos, medicamentos que incluem esses compostos e a utilização dos derivados do ciclohexanol espirocíclicos para a produção de medicamento...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Klaus Linz Michael Jonathan Lipkin Helmut Sonnenschein Stefan Oberdörsch Bernd Sundermann Birgitta Henkel Elmar Friderichs Werner Gunter Englberger Valerie Sarah Rose Otto Aulenbacher Claudia Hinze Hans Schick Babette Yvonne Kögel |
description | "derivados do ciclohexanol espirocíclicos". a invenção está relacionada com os derivados do ciclohexanol espirocíclicos, um método para a produção dos mesmos, medicamentos que incluem esses compostos e a utilização dos derivados do ciclohexanol espirocíclicos para a produção de medicamentos.
Spiro-((4-amino-cyclohexane)-1,1'-1',3',4',9'-tetrahydropyrano-(3,4-b)-indole) derivatives (I) are new. Spiro-cyclic cyclohexylamine derivatives of formula (I), optionally in the form of racemates, pure stereoisomers (especially enantiomers or diastereomers) or their mixtures in all proportions, including free bases, free acids, salts (specifically acid or base addition salt) or solvates (specifically hydrates), are new. [Image] R 1, R 2 : H, optionally unsaturated, optionally mono- or polysubstituted 1-4C alkyl or CHO; R 3 : -(CH 2) n-Aryl; n : 0-2; R 4 : H, optionally unsaturated, optionally mono- or polysubstituted 1-3C alkyl or -CO-(CH 2) m-H; m : 0-2; R 5 - R 8 : H; 1-5C alkyl or 1-3C alkoxy (both optionally unsaturated and optionally mono- or polysubstituted); or halo, OH, SH, SMe, OMe, NH 2, COOH, COOMe, NHMe, NMe 2 or NO 2. ACTIVITY : Analgesic; Tranquilizer; Antidepressant; Anticonvulsant; Neuroprotective; Nootropic; Antiaddictive; Antialcoholic; Vasotropic; Cardiant; Hypotensive; Hypertensive; Auditory; Antipruritic; Antimigraine; Laxative; Anorectic; Antidiarrheic; Immunomodulator; Uropathic; Relaxant; Anesthetic; Diuretic. The hydrochloride of the non-polar diastereomer of 1,1-(3-dimethylamino-3-phenyl-pentamethylene)-1,3,4,9-tetrahydropyrano-(3,4-b)-indole) (Ia) had analgesic ED 5 0 3.5 MicroM i.v. in the mouse tail-flick test. MECHANISM OF ACTION : Nociceptin/ORL1 receptor (opioid receptor like-receptor 1) system modulator; ORL1 receptor ligand. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0315296B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0315296B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0315296B13</originalsourceid><addsrcrecordid>eNqNjDEKAjEQRdNYiHqHwVrBdVGwXVG0E7FfwmQWB5JM2GzEI9l4Ci9mCm222uoX_703Vi9DLT-0kQhGABmt3OmpvVigGLgV_LzRMkpcgCPDqB35ToA92sQ-O4Gs5MvnQnLwz_VqvRgQpJgZGq5M1ajRNtLstxM1Px5u-9OSgtQZ1Uieurq6Xs6rstisd9uqKAdBX_BJXBw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico</title><source>esp@cenet</source><creator>Klaus Linz ; Michael Jonathan Lipkin ; Helmut Sonnenschein ; Stefan Oberdörsch ; Bernd Sundermann ; Birgitta Henkel ; Elmar Friderichs ; Werner Gunter Englberger ; Valerie Sarah Rose ; Otto Aulenbacher ; Claudia Hinze ; Hans Schick ; Babette Yvonne Kögel</creator><creatorcontrib>Klaus Linz ; Michael Jonathan Lipkin ; Helmut Sonnenschein ; Stefan Oberdörsch ; Bernd Sundermann ; Birgitta Henkel ; Elmar Friderichs ; Werner Gunter Englberger ; Valerie Sarah Rose ; Otto Aulenbacher ; Claudia Hinze ; Hans Schick ; Babette Yvonne Kögel</creatorcontrib><description>"derivados do ciclohexanol espirocíclicos". a invenção está relacionada com os derivados do ciclohexanol espirocíclicos, um método para a produção dos mesmos, medicamentos que incluem esses compostos e a utilização dos derivados do ciclohexanol espirocíclicos para a produção de medicamentos.
Spiro-((4-amino-cyclohexane)-1,1'-1',3',4',9'-tetrahydropyrano-(3,4-b)-indole) derivatives (I) are new. Spiro-cyclic cyclohexylamine derivatives of formula (I), optionally in the form of racemates, pure stereoisomers (especially enantiomers or diastereomers) or their mixtures in all proportions, including free bases, free acids, salts (specifically acid or base addition salt) or solvates (specifically hydrates), are new. [Image] R 1, R 2 : H, optionally unsaturated, optionally mono- or polysubstituted 1-4C alkyl or CHO; R 3 : -(CH 2) n-Aryl; n : 0-2; R 4 : H, optionally unsaturated, optionally mono- or polysubstituted 1-3C alkyl or -CO-(CH 2) m-H; m : 0-2; R 5 - R 8 : H; 1-5C alkyl or 1-3C alkoxy (both optionally unsaturated and optionally mono- or polysubstituted); or halo, OH, SH, SMe, OMe, NH 2, COOH, COOMe, NHMe, NMe 2 or NO 2. ACTIVITY : Analgesic; Tranquilizer; Antidepressant; Anticonvulsant; Neuroprotective; Nootropic; Antiaddictive; Antialcoholic; Vasotropic; Cardiant; Hypotensive; Hypertensive; Auditory; Antipruritic; Antimigraine; Laxative; Anorectic; Antidiarrheic; Immunomodulator; Uropathic; Relaxant; Anesthetic; Diuretic. The hydrochloride of the non-polar diastereomer of 1,1-(3-dimethylamino-3-phenyl-pentamethylene)-1,3,4,9-tetrahydropyrano-(3,4-b)-indole) (Ia) had analgesic ED 5 0 3.5 MicroM i.v. in the mouse tail-flick test. MECHANISM OF ACTION : Nociceptin/ORL1 receptor (opioid receptor like-receptor 1) system modulator; ORL1 receptor ligand.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181009&DB=EPODOC&CC=BR&NR=PI0315296B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181009&DB=EPODOC&CC=BR&NR=PI0315296B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Klaus Linz</creatorcontrib><creatorcontrib>Michael Jonathan Lipkin</creatorcontrib><creatorcontrib>Helmut Sonnenschein</creatorcontrib><creatorcontrib>Stefan Oberdörsch</creatorcontrib><creatorcontrib>Bernd Sundermann</creatorcontrib><creatorcontrib>Birgitta Henkel</creatorcontrib><creatorcontrib>Elmar Friderichs</creatorcontrib><creatorcontrib>Werner Gunter Englberger</creatorcontrib><creatorcontrib>Valerie Sarah Rose</creatorcontrib><creatorcontrib>Otto Aulenbacher</creatorcontrib><creatorcontrib>Claudia Hinze</creatorcontrib><creatorcontrib>Hans Schick</creatorcontrib><creatorcontrib>Babette Yvonne Kögel</creatorcontrib><title>derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico</title><description>"derivados do ciclohexanol espirocíclicos". a invenção está relacionada com os derivados do ciclohexanol espirocíclicos, um método para a produção dos mesmos, medicamentos que incluem esses compostos e a utilização dos derivados do ciclohexanol espirocíclicos para a produção de medicamentos.
Spiro-((4-amino-cyclohexane)-1,1'-1',3',4',9'-tetrahydropyrano-(3,4-b)-indole) derivatives (I) are new. Spiro-cyclic cyclohexylamine derivatives of formula (I), optionally in the form of racemates, pure stereoisomers (especially enantiomers or diastereomers) or their mixtures in all proportions, including free bases, free acids, salts (specifically acid or base addition salt) or solvates (specifically hydrates), are new. [Image] R 1, R 2 : H, optionally unsaturated, optionally mono- or polysubstituted 1-4C alkyl or CHO; R 3 : -(CH 2) n-Aryl; n : 0-2; R 4 : H, optionally unsaturated, optionally mono- or polysubstituted 1-3C alkyl or -CO-(CH 2) m-H; m : 0-2; R 5 - R 8 : H; 1-5C alkyl or 1-3C alkoxy (both optionally unsaturated and optionally mono- or polysubstituted); or halo, OH, SH, SMe, OMe, NH 2, COOH, COOMe, NHMe, NMe 2 or NO 2. ACTIVITY : Analgesic; Tranquilizer; Antidepressant; Anticonvulsant; Neuroprotective; Nootropic; Antiaddictive; Antialcoholic; Vasotropic; Cardiant; Hypotensive; Hypertensive; Auditory; Antipruritic; Antimigraine; Laxative; Anorectic; Antidiarrheic; Immunomodulator; Uropathic; Relaxant; Anesthetic; Diuretic. The hydrochloride of the non-polar diastereomer of 1,1-(3-dimethylamino-3-phenyl-pentamethylene)-1,3,4,9-tetrahydropyrano-(3,4-b)-indole) (Ia) had analgesic ED 5 0 3.5 MicroM i.v. in the mouse tail-flick test. MECHANISM OF ACTION : Nociceptin/ORL1 receptor (opioid receptor like-receptor 1) system modulator; ORL1 receptor ligand.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKAjEQRdNYiHqHwVrBdVGwXVG0E7FfwmQWB5JM2GzEI9l4Ci9mCm222uoX_703Vi9DLT-0kQhGABmt3OmpvVigGLgV_LzRMkpcgCPDqB35ToA92sQ-O4Gs5MvnQnLwz_VqvRgQpJgZGq5M1ajRNtLstxM1Px5u-9OSgtQZ1Uieurq6Xs6rstisd9uqKAdBX_BJXBw</recordid><startdate>20181009</startdate><enddate>20181009</enddate><creator>Klaus Linz</creator><creator>Michael Jonathan Lipkin</creator><creator>Helmut Sonnenschein</creator><creator>Stefan Oberdörsch</creator><creator>Bernd Sundermann</creator><creator>Birgitta Henkel</creator><creator>Elmar Friderichs</creator><creator>Werner Gunter Englberger</creator><creator>Valerie Sarah Rose</creator><creator>Otto Aulenbacher</creator><creator>Claudia Hinze</creator><creator>Hans Schick</creator><creator>Babette Yvonne Kögel</creator><scope>EVB</scope></search><sort><creationdate>20181009</creationdate><title>derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico</title><author>Klaus Linz ; Michael Jonathan Lipkin ; Helmut Sonnenschein ; Stefan Oberdörsch ; Bernd Sundermann ; Birgitta Henkel ; Elmar Friderichs ; Werner Gunter Englberger ; Valerie Sarah Rose ; Otto Aulenbacher ; Claudia Hinze ; Hans Schick ; Babette Yvonne Kögel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0315296B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Klaus Linz</creatorcontrib><creatorcontrib>Michael Jonathan Lipkin</creatorcontrib><creatorcontrib>Helmut Sonnenschein</creatorcontrib><creatorcontrib>Stefan Oberdörsch</creatorcontrib><creatorcontrib>Bernd Sundermann</creatorcontrib><creatorcontrib>Birgitta Henkel</creatorcontrib><creatorcontrib>Elmar Friderichs</creatorcontrib><creatorcontrib>Werner Gunter Englberger</creatorcontrib><creatorcontrib>Valerie Sarah Rose</creatorcontrib><creatorcontrib>Otto Aulenbacher</creatorcontrib><creatorcontrib>Claudia Hinze</creatorcontrib><creatorcontrib>Hans Schick</creatorcontrib><creatorcontrib>Babette Yvonne Kögel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Klaus Linz</au><au>Michael Jonathan Lipkin</au><au>Helmut Sonnenschein</au><au>Stefan Oberdörsch</au><au>Bernd Sundermann</au><au>Birgitta Henkel</au><au>Elmar Friderichs</au><au>Werner Gunter Englberger</au><au>Valerie Sarah Rose</au><au>Otto Aulenbacher</au><au>Claudia Hinze</au><au>Hans Schick</au><au>Babette Yvonne Kögel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico</title><date>2018-10-09</date><risdate>2018</risdate><abstract>"derivados do ciclohexanol espirocíclicos". a invenção está relacionada com os derivados do ciclohexanol espirocíclicos, um método para a produção dos mesmos, medicamentos que incluem esses compostos e a utilização dos derivados do ciclohexanol espirocíclicos para a produção de medicamentos.
Spiro-((4-amino-cyclohexane)-1,1'-1',3',4',9'-tetrahydropyrano-(3,4-b)-indole) derivatives (I) are new. Spiro-cyclic cyclohexylamine derivatives of formula (I), optionally in the form of racemates, pure stereoisomers (especially enantiomers or diastereomers) or their mixtures in all proportions, including free bases, free acids, salts (specifically acid or base addition salt) or solvates (specifically hydrates), are new. [Image] R 1, R 2 : H, optionally unsaturated, optionally mono- or polysubstituted 1-4C alkyl or CHO; R 3 : -(CH 2) n-Aryl; n : 0-2; R 4 : H, optionally unsaturated, optionally mono- or polysubstituted 1-3C alkyl or -CO-(CH 2) m-H; m : 0-2; R 5 - R 8 : H; 1-5C alkyl or 1-3C alkoxy (both optionally unsaturated and optionally mono- or polysubstituted); or halo, OH, SH, SMe, OMe, NH 2, COOH, COOMe, NHMe, NMe 2 or NO 2. ACTIVITY : Analgesic; Tranquilizer; Antidepressant; Anticonvulsant; Neuroprotective; Nootropic; Antiaddictive; Antialcoholic; Vasotropic; Cardiant; Hypotensive; Hypertensive; Auditory; Antipruritic; Antimigraine; Laxative; Anorectic; Antidiarrheic; Immunomodulator; Uropathic; Relaxant; Anesthetic; Diuretic. The hydrochloride of the non-polar diastereomer of 1,1-(3-dimethylamino-3-phenyl-pentamethylene)-1,3,4,9-tetrahydropyrano-(3,4-b)-indole) (Ia) had analgesic ED 5 0 3.5 MicroM i.v. in the mouse tail-flick test. MECHANISM OF ACTION : Nociceptin/ORL1 receptor (opioid receptor like-receptor 1) system modulator; ORL1 receptor ligand.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | por |
recordid | cdi_epo_espacenet_BRPI0315296B1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | derivados do ciclohexanol espirocíclicos, medicamento incluindo pelo menos um derivado do ciclohexano espirocíclico e uso de um derivado do ciclohexano espirocíclico |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T03%3A05%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Klaus%20Linz&rft.date=2018-10-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0315296B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |